Aspire-Lakewood Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire-Lakewood Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
Q3 2023 vs. Q2 2023
How the institutions holding Aspire-Lakewood Holdings, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 41 | 40 | −1 |
| Shares | 9.74M | 9.39M | −354.4K (−3.6%) |
| Value | $490.5K | $494.7K | +$4.17K (+0.9%) |
New holders (2)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Meteora Capital, LLC | 25,000 | $1.27K | 0.00% |
| UBS Group AG | 453 | $23 | 0.00% |
Sold out (3)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Kepos Capital LP | 350,000 | $18.0K |
| Landscape Capital Management, L.L.C. | 14,999 | $751 |
| Mangrove Partners | 62,605 | – |